Nexalin Technology (NXL) Net Cash Flow (2021 - 2026)
Nexalin Technology's (NXL) quarterly Net Cash Flow came in at $553112.0 in Q1 2026, up 1063.37% year-on-year from $47544.0 in Q1 2025, and up 754.78% quarter-over-quarter from $64708.0 in Q4 2025.
Nexalin Technology (NXL) Net Cash Flow (2021 - 2026) Analysis & Trends
Nexalin Technology's Net Cash Flow history runs 6 years deep, the most recent figure standing at $553112.0 for Q1 2026.
- On a quarterly basis, Net Cash Flow rose 1063.37% year-over-year to $553112.0 in Q1 2026; TTM through Mar 2026 was -$4.1 million, a 8.56% increase from a year earlier, with the FY2025 full-year figure at $80298.0, up 1497.7% from the prior year.
- Net Cash Flow rose to $553112.0 in Q1 2026 per NXL's latest filing, from $64708.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $7.6 million in Q3 2022 and bottomed at -$5.3 million in Q3 2024.
- The 5-year median for Net Cash Flow is $56761.0 (2023), against an average of -$107152.0.
- Across the five-year window, Net Cash Flow tumbled 4174.46% in 2024 and surged 1063.37% in 2026, its largest moves.
- Year by year, Net Cash Flow stood at -$906457.0 in 2022, then soared by 124.14% to $218834.0 in 2023, then jumped by 125.31% to $493064.0 in 2024, then slumped by 86.88% to $64708.0 in 2025, then surged by 754.78% to $553112.0 in 2026.
- Per Business Quant, the three latest NXL Net Cash Flow figures stand at $553112.0 (Q1 2026), $64708.0 (Q4 2025), and $158755.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 | 553,112.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 553,112.00 |
| Mar 31, 2026 | 553,112.00 |
| Dec 31, 2025 | 64,708.00 |
| Dec 31, 2025 | 64,708.00 |
| Sep 30, 2025 | 158,755.00 |
| Sep 30, 2025 | 158,755.00 |
| Jun 30, 2025 | -4.84 Mn |
| Jun 30, 2025 | -4.84 Mn |
| Mar 31, 2025 | 47,544.00 |
| Mar 31, 2025 | 47,544.00 |
| Dec 31, 2024 | 493,064.00 |
| Dec 31, 2024 | 493,064.00 |
| Sep 30, 2024 | -5.28 Mn |
| Sep 30, 2024 | -5.28 Mn |
| Jun 30, 2024 | 302,541.00 |
| Jun 30, 2024 | 302,541.00 |
| Mar 31, 2024 | -33,975.00 |
| Mar 31, 2024 | -33,975.00 |
| Dec 31, 2023 | 218,834.00 |
| Dec 31, 2023 | 218,834.00 |